microarray gene expression
Recently Published Documents


TOTAL DOCUMENTS

919
(FIVE YEARS 153)

H-INDEX

65
(FIVE YEARS 6)

2022 ◽  
Vol 23 (1) ◽  
pp. 560
Author(s):  
Mouna Tabebi ◽  
Ravi Kumar Dutta ◽  
Camilla Skoglund ◽  
Peter Söderkvist ◽  
Oliver Gimm

Background: Enzymes of tricarboxylic acid (TCA) have recently been recognized as tumor suppressors. Mutations in the SDHB subunit of succinate dehydrogenase (SDH) cause pheochromocytomas and paragangliomas (PCCs/PGLs) and predispose patients to malignant disease with poor prognosis. Methods: Using the human pheochromocytoma cell line (hPheo1), we knocked down SDHB gene expression using CRISPR-cas9 technology. Results: Microarray gene expression analysis showed that >500 differentially expressed gene targets, about 54%, were upregulated in response to SDHB knock down. Notably, genes involved in glycolysis, hypoxia, cell proliferation, and cell differentiation were up regulated, whereas genes involved in oxidative phosphorylation (OXPHOS) were downregulated. In vitro studies show that hPheo1 proliferation is not affected negatively and the cells that survive by shifting their metabolism to the use of glutamine as an alternative energy source and promote OXPHOS activity. Knock down of SDHB expression results in a significant increase in GLUD1 expression in hPheo1 cells cultured as monolayer or as 3D culture. Analysis of TCGA data confirms the enhancement of GLUD1 in SDHB mutated/low expressed PCCs/PGLs. Conclusions: Our data suggest that the downregulation of SDHB in PCCs/PGLs results in increased GLUD1 expression and may represent a potential biomarker and therapeutic target in SDHB mutated tumors and SDHB loss of activity-dependent diseases.


2021 ◽  
Author(s):  
Kensuke Tanioka ◽  
Yuki Furotani ◽  
Satoru Hiwa

Background: Low-rank approximation is a very useful approach for interpreting the features of a correlation matrix; however, a low-rank approximation may result in estimation far from zero even if the corresponding original value was far from zero. In this case, the results lead to misinterpretation. Methods: To overcome these problems, we propose a new approach to estimate a sparse low-rank correlation matrix based on threshold values combined with cross-validation. In the proposed approach, the MM algorithm was used to estimate the sparse low-rank correlation matrix, and a grid search was performed to select the threshold values related to sparse estimation. Results: Through numerical simulation, we found that the FPR and average relative error of the proposed method were superior to those of the tandem approach. For the application of microarray gene expression, the FPRs of the proposed approach with d=2,3, and 5 were 0.128, 0.139, and 0.197, respectively, while FPR of the tandem approach was 0.285. Conclusions: We propose a novel approach to estimate sparse low-rank correlation matrix. The advantage of the proposed method is that it provides results that are easy to interpret and avoid misunderstandings. We demonstrated the superiority of the proposed method through both numerical simulations and real examples.


Biomedicines ◽  
2021 ◽  
Vol 9 (12) ◽  
pp. 1937
Author(s):  
Antonio Lacalamita ◽  
Emanuele Piccinno ◽  
Viviana Scalavino ◽  
Roberto Bellotti ◽  
Gianluigi Giannelli ◽  
...  

Colorectal cancer (CRC) carcinogenesis is generally the result of the sequential mutation and deletion of various genes; this is known as the normal mucosa–adenoma–carcinoma sequence. The aim of this study was to develop a predictor-classifier during the “adenoma-carcinoma” sequence using microarray gene expression profiles of primary CRC, adenoma, and normal colon epithelial tissues. Four gene expression profiles from the Gene Expression Omnibus database, containing 465 samples (105 normal, 155 adenoma, and 205 CRC), were preprocessed to identify differentially expressed genes (DEGs) between adenoma tissue and primary CRC. The feature selection procedure, using the sequential Boruta algorithm and Stepwise Regression, determined 56 highly important genes. K-Means methods showed that, using the selected 56 DEGs, the three groups were clearly separate. The classification was performed with machine learning algorithms such as Linear Model (LM), Random Forest (RF), k-Nearest Neighbors (k-NN), and Artificial Neural Network (ANN). The best classification method in terms of accuracy (88.06 ± 0.70) and AUC (92.04 ± 0.47) was k-NN. To confirm the relevance of the predictive models, we applied the four models on a validation cohort: the k-NN model remained the best model in terms of performance, with 91.11% accuracy. Among the 56 DEGs, we identified 17 genes with an ascending or descending trend through the normal mucosa–adenoma–carcinoma sequence. Moreover, using the survival information of the TCGA database, we selected six DEGs related to patient prognosis (SCARA5, PKIB, CWH43, TEX11, METTL7A, and VEGFA). The six-gene-based classifier described in the current study could be used as a potential biomarker for the early diagnosis of CRC.


2021 ◽  
Vol 2021 ◽  
pp. 1-12
Author(s):  
Meng Zhou ◽  
Dacheng Wang ◽  
Jing Tang

Objectives. Osteoarthritis (OA) is a chronic joint degenerative disease and has become an important health problem for the elderly. However, there is still a lack of effective drugs for the treatment of OA. Our research combines bioinformatics and experimental strategies to determine the target of resveratrol for OA treatment. Methods. First, the differentially expressed genes (DEGs) of OA joint tissues were obtained from the related microarray gene expression data. Second, resveratrol, a natural polyphenol compound, was used to screen the drug treatment target genes. Third, the drug-disease network was established, and the resveratrol target genes for OA treatment were obtained and verified through experimental verification. Results. A total of 300 differentially expressed genes with 246 upregulated and 54 downregulated were found in OA joint tissues, and 310 resveratrol potential target genes were obtained. Finally, six genes, namely, CXCL1, HIF1A, IL-6, MMP3, NOX4, and PTGS2, were selected to validate the treatment effects of the resveratrol. The results showed that all six genes in human OA chondrocytes were significantly increased. In addition, in these chondrocytes, CXCL1, HIF1A, IL-6, MMP3, NOX4, and PTGS2 were reduced considerably, but HIF1A was significantly increased after resveratrol treatment. Conclusions. Our data indicates that CXCL1, HIF1A, IL-6, MMP3, NOX4, and PTGS2 are all targets of resveratrol therapy. Our findings may provide valuable information for the mechanism and therapeutic of OA.


2021 ◽  
Author(s):  
Justine Y Hansen ◽  
Ross D Markello ◽  
Lauri Tuominen ◽  
Martin Norgaard ◽  
Elena Kuzmin ◽  
...  

Neurotransmitter receptors modulate the signaling between neurons. Thus, neurotransmitter receptors and transporters play a key role in shaping brain function. Due to the lack of comprehensive neurotransmitter receptor/transporter density datasets, microarray gene expression is often used as a proxy for receptor densities. In the present report, we comprehensively test the expression-density association for a total of 27 neurotransmitter receptors, receptor binding-sites, and transporters across 9 different neurotransmitter systems, using both PET and autoradiography imaging modalities. We find poor spatial correspondences between gene expression and density for all neurotransmitter receptors and transporters except four single-protein metabotropic receptors (5-HT1A, D2, CB1, and MOR). These expression-density associations are related to population variance and change across different classes of laminar differentiation. Altogether, we recommend using direct measures of receptor and transporter density when relating neurotransmitter systems to brain structure and function.


2021 ◽  
Vol 12 (45) ◽  
pp. 162-167
Author(s):  
Anisur Rahman Khuda-Bukhsh ◽  
Santu Kumar Saha ◽  
Sourav Roy

Background: Use of ultra-high diluted remedies in homeopathy and their claimed efficacy in curing diseases has been challenged time and again by non-believers despite many evidence-based positive results published in favor of their efficacy in curing/ameliorating disease symptoms. Aims: To test the ability of ultra-high diluted homeopathic remedies beyond Avogadro’s limit, if any, in manifesting gene modulating effects in controlled in vitro experimental model. Methods: Since cancer cells manifest aberrant epigenetic gene expressions, we conducted global microarray gene expression profiling of HeLa cells (an established epigenetic model of HPV18 positive cell line) treated with two different potentized homeopathic remedies, namely, Condurango 30c and Hydrastis canadensis 30C (used in the treatment of cancer), as compared to that of placebo (succussed alcohol 30c). Results: Data revealed distinctly different expression patterns of over 100 genes as a consequence of treatment with both homeopathc remedies compared to placebo. Conclusion: Results indicate that action of the potentized drugs was “more than placebo” and these ultra-highly diluted drugs acted primarily through modulation of gene expression.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Aditya Dubey ◽  
Akhtar Rasool

AbstractFor most bioinformatics statistical methods, particularly for gene expression data classification, prognosis, and prediction, a complete dataset is required. The gene sample value can be missing due to hardware failure, software failure, or manual mistakes. The missing data in gene expression research dramatically affects the analysis of the collected data. Consequently, this has become a critical problem that requires an efficient imputation algorithm to resolve the issue. This paper proposed a technique considering the local similarity structure that predicts the missing data using clustering and top K nearest neighbor approaches for imputing the missing value. A similarity-based spectral clustering approach is used that is combined with the K-means. The spectral clustering parameters, cluster size, and weighting factors are optimized, and after that, missing values are predicted. For imputing each cluster’s missing value, the top K nearest neighbor approach utilizes the concept of weighted distance. The evaluation is carried out on numerous datasets from a variety of biological areas, with experimentally inserted missing values varying from 5 to 25%. Experimental results prove that the proposed imputation technique makes accurate predictions as compared to other imputation procedures. In this paper, for performing the imputation experiments, microarray gene expression datasets consisting of information of different cancers and tumors are considered. The main contribution of this research states that local similarity-based techniques can be used for imputation even when the dataset has varying dimensionality and characteristics.


Hereditas ◽  
2021 ◽  
Vol 158 (1) ◽  
Author(s):  
Hong Lin Zu ◽  
Hong Wei Liu ◽  
Hai Yang Wang

Abstract Background The diameter of the abdominal aortic aneurysm (AAA) is the most commonly used parameter for the prediction of occurrence of AAA rupture. However, the most vulnerable region of the aortic wall may be different from the most dilated region of AAA under pressure. The present study is the first to use weighted gene coexpression network analysis (WGCNA) to detect the coexpressed genes that result in regional weakening of the aortic wall. Methods The GSE165470 raw microarray dataset was used in the present study. Differentially expressed genes (DEGs) were filtered using the “limma” R package. DEGs were assessed by Gene Ontology biological process (GO-BP) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses. WGCNA was used to construct the coexpression networks in the samples with regional weakening of the AAA wall and in the control group to detect the gene modules. The hub genes were defined in the significant functional modules, and a hub differentially expressed gene (hDEG) coexpression network was constructed with the highest confidence based on protein–protein interactions (PPIs). Molecular compound detection (MCODE) was used to identify crucial genes in the hDEG coexpression network. Crucial genes in the hDEG coexpression network were validated using the GSE7084 and GSE57691 microarray gene expression datasets. Result A total of 350 DEGs were identified, including 62 upregulated and 288 downregulated DEGs. The pathways were involved in immune responses, vascular smooth muscle contraction and cell–matrix adhesion of DEGs in the samples with regional weakening in AAA. Antiquewhite3 was the most significant module and was used to identify downregulated hDEGs based on the result of the most significant modules negatively related to the trait of weakened aneurysm walls. Seven crucial genes were identified and validated: ACTG2, CALD1, LMOD1, MYH11, MYL9, MYLK, and TPM2. These crucial genes were associated with the mechanisms of AAA progression. Conclusion We identified crucial genes that may play a significant role in weakening of the AAA wall and may be potential targets for medical therapies and diagnostic biomarkers. Further studies are required to more comprehensively elucidate the functions of crucial genes in the pathogenesis of regional weakening in AAA.


Cancers ◽  
2021 ◽  
Vol 13 (21) ◽  
pp. 5523
Author(s):  
Daugrois Camille ◽  
Bessiere Chloé ◽  
Dejean Sébastien ◽  
Anton Leberre Véronique ◽  
Commes Thérèse ◽  
...  

Anaplastic large cell lymphomas associated with ALK translocation have a good outcome after CHOP treatment; however, the 2-year relapse rate remains at 30%. Microarray gene-expression profiling of 48 samples obtained at diagnosis was used to identify 47 genes that were differentially expressed between patients with early relapse/progression and no relapse. In the relapsing group, the most significant overrepresented genes were related to the regulation of the immune response and T-cell activation while those in the non-relapsing group were involved in the extracellular matrix. Fluidigm technology gave concordant results for 29 genes, of which FN1, FAM179A, and SLC40A1 had the strongest predictive power after logistic regression and two classification algorithms. In parallel with 39 samples, we used a Kallisto/Sleuth pipeline to analyze RNA sequencing data and identified 20 genes common to the 28 genes validated by Fluidigm technology—notably, the FAM179A and FN1 genes. Interestingly, FN1 also belongs to the gene signature predicting longer survival in diffuse large B-cell lymphomas treated with CHOP. Thus, our molecular signatures indicate that the FN1 gene, a matrix key regulator, might also be involved in the prognosis and the therapeutic response in anaplastic lymphomas.


Sign in / Sign up

Export Citation Format

Share Document